TACSTD2 and anaplastic large cell lymphoma: Hematologic malignancies, including leukaemia, ENK/TL, and NHL, exhibit upregulated TROP-2, while anaplastic large cell lymphoma (ALCL) shows no TROP-2 expression [21].